Tradestie Institutional Equity Comparison Engine

SLS vs VIVS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLS Overall Edge

SLS Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SELLAS Life Sciences Group, Inc. Common Stock (SLS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SLS trades at N/M Forward P/E with 0.0% operating margin (-82.5% YoY revenue) versus VIVS at N/M Forward P/E and -10117.0% operating margin (-51.4% YoY). In options structure, SLS sits in CONSOLIDATION (16th %ile IV; Dealer Gamma Walls on Pro) against VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SLS N/M vs VIVS N/M Fwd P/E
Growth & Margin Winner SLS
Op Margin 0.0% vs -10117.0% ยท YoY -82.5% vs -51.4%
Momentum & Technical Winner SLS
1Y +834.6% vs -87.0% ยท 52W Pos 57% vs 5%
Options & Structure Winner SLS
CONSOLIDATION (16th %ile IV) vs BREAKDOWN (N/A IV)
SLS NASDAQ
SELLAS Life Sciences Group, Inc. Common Stock
Pharmaceutical Preparations
$14.86
-17.21% 1D
Market Cap $3.7B
1M Return +22.41%
1Y Return +834.59%
Forward P/E N/M
Unified AI Score
39.3 / 100 SELL
Tech 50.0 Fund 37.0 Flow 68.0 Mom 48.9
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
1M Return +64.69%
1Y Return -86.99%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 5.0 Fund 38.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SLS +834.59% VIVS -86.99% Spread: +921.58 pp (SLS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SLS Revenue VIVS Revenue SLS Op. Margin VIVS Op. Margin Margin Edge
FY2019 N/A $0M N/A -882.4% VIVS
FY2020 $0M $0M -893.8% -977.9% SLS
FY2021 $10M N/A -332.8% N/A SLS
FY2022 $0M $0M -4195.0% -765.3% VIVS
FY2023 N/A $0M N/A -4792.2% VIVS
FY2024 N/A $0M N/A -13840.4% VIVS
FY2025 N/A $0M N/A -8761.1% VIVS
FY2026 N/A $0M N/A -8768.7% VIVS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SLS (5) vs VIVS (2)
Institutional Metric SLS VIVS Criterion Row Winner
Market Capitalization Scale $3.7B $2.4M Larger Scale SLS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -82.5% -51.4% Higher Growth VIVS
Operating Margin (TTM) Profitability 0.0% -10117.0% Higher Margin SLS
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -40.3% -343.1% Higher ROE SLS
52-Week Range Position Momentum 57% ($1โ€“$25) 5% ($0โ€“$3) Stronger Trend SLS
Beta / 30D Volatility Risk Regime 1.84ฮฒ ยท 551% Vol 0.83ฮฒ ยท 480% Vol Lower Realized Risk VIVS
Unified Institutional Score Composite Signal 39.3 / 100 (SELL) 36.8 / 100 (SELL) Higher Composite SLS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SLS vs VIVS Buy Guide
SLS CONSOLIDATION
101d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live SLS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VIVS BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VIVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SLS nor VIVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.